🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

.Markey Cancer Center has provided state-of-the-art cancer care for more than 20 years, and in 2019, Markey Cancer Center was named the No. 33 ranked cancer center in the nation by @USNews. Learn more about what sets us apart. ukhealthcare.uky.edu/markey-cancer-…

The fourth annual Hematology and Immunotherapy review will be held on February 1 at the Hilary J. Boone Center. Learn more or register. cecentral.com/live/17591

CAR-T cell could lead to very prolonged bone marrow aplasia. We present an unusual case which was salvaged by an allogenic transplant. ⁦Markey Cancer Center⁩ ⁦Reshma Ramlal⁩ ⁦Gerhard Hildebrandt⁩ onlinelibrary.wiley.com/doi/pdf/10.100…

Final talk of the day given by our fellow Dr Qasrawi on Benign Hematology. Incredible reminder of what is going on in that field !

How I treat Relapsed Myeloma: First relapse. #myelomaVR I’m trying a new style for algorithms based on most common clinical scenarios instead of usual algorithms that list various options. #mmsm Mayo Myeloma Mohamad Mohty Mike Thompson, MD, PhD, FASCO @MyelomaTeacher - Cindy Chmielewski Yelak Biru Jim Omel 1/

KRD vs VRD phase III ENDURANCE trial out in ASCO abstract! ❌no PFS difference ❌no OS difference “An example of why we need to wait for phase III data before changing practice.” - @AnthonyPerissi2 🎤 🤓 #ASCO2020 #mmsm #micdrop meetinglibrary.asco.org/record/186906/…

I just read an old case report that made me gasp. Mom is transporting chocolate agar plates from clinic to lab (used to identify gonorrhea, looks like chocolate is made form blood) with 3 year old. Pops into store. Finds child snacked on culture plates.

I don’t understand why the National Comprehensive Cancer Network (NCCN) guidelines PDFs are protected. We can’t even highlight or underline or anything. What’s the risk in making those PDFs editable?

What a way to finish clinic and start the weekend. Turned my awesome fellow Ayman Qasrawi (who is going on to be a BMT doc) into a PRRT believer on his last day of NET clinic with me.G2 pNET s/pSSA, Sutent and CAPTEM, now after 4 doses PRRT and tumors shrank from 6 cm to1.4 cm🍻

My grant got rejected. I failed. So I'm saying it on Twitter. I don't want sympathy. I just wish people would say stuff like this on Twitter.

I just realized that I received "ASH abstract achievement award". Yes! it is 3 weeks after the #ASH20 and thanks for my email that sorted the email as a "junk" 😂. Thanks for my co-fellow Ayman Qasrawi and for my mentors UNMC Heme Onc @Dr_MBaljevic Gerhard Hildebrandt Julie Vose

Our collaborative study with the UNMC about adverse prognostic factors in HLH won the 2020 ASH Achievement Award!! Collaboration is the cornerstone of successful research! Omar Abu Ghanimeh UNMC Heme Onc Markey Cancer Center Gerhard Hildebrandt Julie Vose @Dr_MBaljevic UK HealthCare

Omar Abu Ghanimeh Ayman Qasrawi UNMC Heme Onc Gerhard Hildebrandt Julie Vose Proud of our fellow Dr. Abughanimeh #UNMC and his colleague Dr. Qasrawi #UKMarkey for their fantastic work and merit ASH Award 2020 on what predicts to be the biggest retrospective cohort with US experience in secondary HLH - in collaboration with Gerhard Hildebrandt UNMC Heme Onc

Fellowship interview season begins today! Super excited to meet our candidates 😃 UK HemOnc Fellows

UKY Markey Cancer Center Faculty and Fellows at #ASH23 San Diego - making time for fun selfies UK HemOnc Fellows.

If you are National Comprehensive Cancer Network (NCCN) this weekend, pass by and see our poster on the comparison of somatic mutations and ELN classification between Appalachian and non-Appalachian Kentucky Reshma Ramlal

🚨🚨 In the FIRST of its kind study, we laid down the basis how to use immune therapy to prevent #cancer. 👉 “Can immune therapy prevent pre-clinical cancer from progression? The impact of immune therapy on secondary cancer incidence.” Please check out our abstract in